Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT04535856
Eligibility Criteria:
Inclusion Criteria:
1. Age of 19 years or older at the time of screening
2. Those who have been confirmed COVID-19 infection through PCR test
3. Patients with mild or moderate COVID-19 who meet National EWS (0\~6)
4. Those who have given written consent and voluntarily decided to participate before the screening procedure after understanding the detailed description of the clinical trial.
5. Those who are suitable as subjects for this clinical study when judged by physical examination, clinical laboratory test, and other medical examination as stated in the flowchart of protocol.
Exclusion Criteria:
1. Those who have history of hypersensitivity to the components of the investigational product or the reference product
2. Those with viral or bacterial pneumonia other than expected indications
3. Patients receiving organ transplants within 6 months of screening
4. Patients with a history of pulmonary embolism
5. Patients who have indications of investigational products as an underlying disease (ex. HIV patients in the clinical study of antiretroviral drugs)
6. Patients who are pregnant or lactating
7. Those who are determined by the investigator to be unsuitable for participation in the clinical trial due to other reasons including the results of the clinical laboratory test.
8. Patients participating in other clinical studies
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04535856
Study Brief:
Protocol Section:
NCT04535856